Abstract
Right ventricular (RV) structure and function influence the morbidity and mortality from coronary artery disease (CAD), dilated cardiomyopathy (DCM), pulmonary hypertension and heart failure. Little is known about the genetic basis of RV measurements. Here we perform genome-wide association analyses of four clinically relevant RV phenotypes (RV end-diastolic volume, RV end-systolic volume, RV stroke volume, RV ejection fraction) from cardiovascular magnetic resonance images, using a state-of-the-art deep learning algorithm in 29,506 UK Biobank participants. We identify 25 unique loci associated with at least one RV phenotype at P < 2.27 ×10−8, 17 of which are validated in a combined meta-analysis (n = 41,830). Several candidate genes overlap with Mendelian cardiomyopathy genes and are involved in cardiac muscle contraction and cellular adhesion. The RV polygenic risk scores (PRSs) are associated with DCM and CAD. The findings substantially advance our understanding of the genetic underpinning of RV measurements.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Summary GWAS statistics are publicly available on the GWAS catalog portal (https://www.ebi.ac.uk/gwas/). The web links for the publicly available datasets used in the study are as follows: ANNOVAR (https://annovar.openbioinformatics.org/en/latest/user-guide/download/), PhenoScanner version 2 (http://www.phenoscanner.medschl.cam.ac.uk), GWAS catalog (https://www.ebi.ac.uk/gwas/docs/file-downloads), GTEx version 7 and version 8 eQTL results (https://gtexportal.org/home/datasets), CADD version 1.6 (https://cadd.gs.washington.edu/download) and RegulomeDB version 2 (https://regulomedb.org/regulome-search). All other data are contained in the article file and its supplementary information or are available upon request.
Code availability
Publicly available software tools were used to perform genetic analyses. These tools include BOLT, MTAG, LDSC, probABEL, GWAMA, eCaviar, DEPICT, S-MultiXcan (https://github.com/hakyimlab/MetaXcan), MAGMA, FUMA, g:Profiler, g:Profiler and PheWAS R package. The algorithms for CMR image analysis are available in https://github.com/baiwenjia/ukbb_cardiac. For automated CMR image analysis, we used python v3.6 and tensorflow v1.9.0. Manual analysis of CMR studies was performed using cvi42 software (v5.1.1) (https://www.circlecvi.com).
References
Walker, L. A. & Buttrick, P. M. The right ventricle: biologic insights and response to disease: updated. Curr. Cardiol. Rev. 9, 73–81 (2013).
Chatterjee, N. A. et al. Right ventricular structure and function are associated with incident atrial fibrillation. Circ. Arrhythm. Electrophysiol. 10, e004738 (2017).
Naksuk, N. et al. Right ventricular dysfunction and long-term risk of sudden cardiac death in patients with and without severe left ventricular dysfunction. Circ. Arrhythm. Electrophysiol. 11, e006091 (2018).
Noordegraaf, A. V. & Galiè, N. The role of the right ventricle in pulmonary arterial hypertension. Eur. Respir. Rev. 20, 243–253 (2011).
Voelkel, N. F. et al. Right ventricular function and failure. Circulation 114, 1883–1891 (2006).
Shah, P. K. et al. Variable spectrum and prognostic implications of left and right ventricular ejection fractions in patients with and without clinical heart failure after acute myocardial infarction. Am. J. Cardiol. 58, 387–393 (1986).
Polak, J. F., Holman, B. L., Wynne, J. & Colucci, W. S. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J. Am. Coll. Cardiol. 2, 217–224 (1983).
Groote, Pde et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J. Am. Coll. Cardiol. 32, 948–954 (1998).
Di Salvo, T. G., Mathier, M., Semigran, M. J. & Dec, G. W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J. Am. Coll. Cardiol. 25, 1143–1153 (1995).
Gavazzi, A. et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J. Heart Lung Transplant. 16, 774–785 (1997).
Ghio, S. et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol. 37, 183–188 (2001).
Mendes, L. A. et al. Right ventricular dysfunction: An independent predictor of adverse outcome in patients with myocarditis. Am. Heart J. 128, 301–307 (1994).
Juillière, Y. et al. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur. Heart J. 18, 276–280 (1997).
Gulati, A. et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 128, 1623–1633 (2013).
Kawut, S. M. et al. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)—right ventricle study. Circulation 126, 1681–1688 (2012).
Modin, D., Møgelvang, R., Andersen, D. M. & Biering-Sørensen, T. Right ventricular function evaluated by tricuspid annular plane systolic excursion predicts cardiovascular death in the general population. J. Am. Heart Assoc. 8, e012197 (2019).
Apostolakis, S. & Konstantinides, S. The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management. Cardiology 121, 263–273 (2012).
Vasan, R. S. et al. Genetic variants associated with cardiac structure and function. JAMA 302, 168–178 (2009).
Wild, P. S. et al. Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J. Clin. Invest. 127, 1798–1812 (2017).
Kanai, M. et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 50, 390–400 (2018).
Aung, N. et al. Genome-wide analysis of left ventricular image-derived phenotypes identifies fourteen loci associated with cardiac morphogenesis and heart failure development. Circulation 140, 1318–1330 (2019).
Pirruccello, J. P. et al. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nat. Commun. 11, 2254 (2020).
Grothues, F. et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am. Heart J. 147, 218–223 (2004).
Bai, W. et al. Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J. Cardiovasc. Magn. Reson. 20, 65 (2018).
Ronneberger, O., Fischer, P. & Brox, T. U-Net: convolutional networks for biomedical image segmentation. In Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015 (Eds. Navab, N., Hornegger, J., Wells, W. M. & Frangi, A. F.) 234–241 (Springer International Publishing, 2015).
Petersen, S. E. et al. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J. Cardiovasc. Magn. Reson. 19, 18 (2017).
Staley, J. R. et al. PhenoScanner: a database of human genotype–phenotype associations. Bioinformatics 32, 3207–3209 (2016).
Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790–1797 (2012).
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886–D894 (2019).
Hormozdiari, F. et al. Colocalization of GWAS and eQTL signals detects target genes. Am. J. Hum. Genet. 99, 1245–1260 (2016).
Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
Barbeira, A. N. et al. Integrating predicted transcriptome from multiple tissues improves association detection. PLoS Genet. 15, e1007889 (2019).
Leeuw, C. A., de, Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
Udovcic, M., Pena, R. H., Patham, B., Tabatabai, L. & Kansara, A. Hypothyroidism and the heart. Methodist DeBakey Cardiovasc. J. 13, 55–59 (2017).
Meyer, H. V. et al. Genetic and functional insights into the fractal structure of the heart. Nature 584, 589–594 (2020).
Lahm, H. et al. Congenital heart disease risk loci identified by genome-wide association study in European patients. J. Clin. Invest. 131, e141837 (2021).
Hedberg-Oldfors, C. et al. Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles. Brain 143, 2406–2420 (2020).
Kontrogianni-Konstantopoulos, A., Ackermann, M. A., Bowman, A. L., Yap, S. V. & Bloch, R. J. Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol. Rev. 89, 1217–1267 (2009).
Hu, L.-Y. R. et al. Deregulated Ca2+ cycling underlies the development of arrhythmia and heart disease due to mutant obscurin. Sci. Adv. 3, e1603081 (2017).
Parast, M. M. & Otey, C. A. Characterization of Palladin, a novel protein localized to stress fibers and cell adhesions. J. Cell Biol. 150, 643–656 (2000).
Garrod, D. & Chidgey, M. Desmosome structure, composition and function. Biochim. Biophys. Acta Biomembr. 1778, 572–587 (2008).
Marston, S. Obscurin variants and inherited cardiomyopathies. Biophys. Rev. 9, 239–243 (2017).
Ushijima, T. et al. The actin-organizing formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice. J. Biol. Chem. 293, 148–162 (2018).
Esslinger, U. et al. Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS One 12, e0172995 (2017).
Carniel, E. et al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112, 54–59 (2005).
Peng, W. et al. Dysfunction of myosin light-chain 4 (MYL4) leads to heritable atrial cardiomyopathy with electrical, contractile, and structural components: evidence from genetically-engineered rats. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 6, e007030 (2017).
Merner, N. D. et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am. J. Hum. Genet. 82, 809–821 (2008).
Bai, W. et al. A population-based phenome-wide association study of cardiac and aortic structure and function. Nat. Med. 26, 1654–1662 (2020).
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
Petersen, S. E. et al. UK Biobank’s cardiovascular magnetic resonance protocol. J. Cardiovasc. Magn. Reson. 18, 8 (2015).
Simonyan, K. & Zisserman, A. Very deep convolutional networks for large-scale image recognition. In International Conference on Learning Representations. Preprint at arXiv https://arxiv.org/abs/1409.1556 (2015).
Kingma, D. P. & Ba, J. Adam: a method for stochastic optimization. In International Conference on Learning Representations. Preprint at arXiv https://arxiv.org/abs/1412.6980 (2017).
Abadi, M. et al. TensorFlow: a system for large-scale machine learning. In Proc. 12th USENIX Symposium on Operating Systems Design and Implementation (OSDI 16) 265–283 (2016).
Chang, W., Cheng, J., Allaire, J., Xie, Y. & McPherson, J. shiny: Web Application Framework for R https://CRAN.R-project.org/package=shiny (2018).
Loh, P.-R. et al. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat. Genet. 47, 1385–1392 (2015).
Tobin, M. D., Sheehan, N. A., Scurrah, K. J. & Burton, P. R. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat. Med. 24, 2911–2935 (2005).
Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 50, 229–237 (2018).
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
Chahal, H. et al. Relation of cardiovascular risk factors to right ventricular structure and function as determined by magnetic resonance imaging (results from the multi-ethnic study of atherosclerosis). Am. J. Cardiol. 106, 110–116 (2010).
Aulchenko, Y. S., Struchalin, M. V. & van Duijn, C. M. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinf. 11, 134 (2010).
Mägi, R. & Morris, A. P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinf. 11, 288 (2010).
Wakefield, J. Bayes factors for genome-wide association studies: comparison with P-values. Genet. Epidemiol. 33, 79–86 (2009).
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
Watanabe, K., Taskesen, E., Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
Reimand, J. et al. g:Profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 44, W83–W89 (2016).
Reimand, J., Kull, M., Peterson, H., Hansen, J. & Vilo, J. g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193–W200 (2007).
Wu, P. et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med. Inform. 7, e14325 (2019).
Acknowledgements
This research was conducted using the UK Biobank Resource under application 2964. We thank all UK Biobank participants and staff. N.A. recognizes the National Institute for Health Research Integrated Academic Training program, which supports his Academic Clinical Lectureship post, and also acknowledges support from the Wellcome Trust (Research Training Fellowship 203553/Z/16/Z). We acknowledge the British Heart Foundation for funding the manual analysis to create a CMR imaging reference standard for the UK Biobank imaging resource in 5,000 CMR scans (PG/14/89/31194; S.K.P., S.N. and S.E.P.). We also acknowledge support from the ‘SmartHeart’ Engineering and Physical Sciences Research Council program grant (EP/P001009/1; S.E.P.). The Oxford National Institute for Health Research Biomedical Research Centre and the Oxford British Heart Foundation Centre of Research Excellence supported this research (S.K.P. and S.N.). This work was part of the portfolio of translational research of the National Institute for Health Research Biomedical Research Centre at Barts and The London School of Medicine and Dentistry (N.A., P.B.M. and S.E.P.). This project was enabled through access to the Medical Research Council eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (grant MR/L016311/1; S.E.P.). The UK Biobank was established by the Wellcome Trust medical charity, the Medical Research Council, the Department of Health, the Scottish Government and the Northwest Regional Development Agency. It has also received funding from the Welsh Assembly Government and the British Heart Foundation. MESA and the MESA SHARe projects are conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079 UL1-TR-001420 from NHLBI and NIH. Funding for SHARe genotyping was provided by National Heart, Lung, and Blood Institute contract N02-HL-64278. Genotyping in MESA was performed at Affymetrix (Santa Clara, CA) and the Broad Institute of Harvard and MIT (Boston, MA) using the Affymetrix Genome-Wide Human SNP Array 6.0. The study was also supported in part by the National Center for Advancing Translational Sciences grant UL1TR001881 and National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center grant DK063491 to the Southern California Diabetes Endocrinology Research Center. RV phenotyping in MESA was funded by National Institutes of Health grants K24 HL103844 and R01 HL086719.
Author information
Authors and Affiliations
Contributions
N.A. conceived the study, designed the methodology, performed manual and automated segmentation of CMR studies, carried out genetic and bioinformatic analyses and drafted and finalized the manuscript. J.D.V. conceived the study and revised the manuscript. C.Y. and A.M. performed statistical analysis of MESA data. J.I.R., K.D.T., J.A.C.L., D.A.B. and S.M.K. substantively revised the manuscript. K.F. performed manual segmentation of CMR studies. M.M.S. performed manual segmentation of CMR studies and contributed to the writing of specific sections. S.K.P. and S.N. supervised CMR image segmentation and acquired funding. S.E.P. and P.B.M. conceived the study, designed the methodology, provided supervision, acquired funding and edited the manuscript. All authors read the paper and contributed to its final form.
Corresponding authors
Ethics declarations
Competing interests
S.E.P. acts as a consultant for and is shareholder of Circle Cardiovascular Imaging (Calgary, Alberta, Canada). All other authors have no competing interests.
Peer review
Peer review information
Nature Genetics thanks the anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Figures 1–9.
Supplementary Table 1
Supplementary Tables 1–15.
Rights and permissions
About this article
Cite this article
Aung, N., Vargas, J.D., Yang, C. et al. Genome-wide association analysis reveals insights into the genetic architecture of right ventricular structure and function. Nat Genet 54, 783–791 (2022). https://doi.org/10.1038/s41588-022-01083-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-022-01083-2
This article is cited by
-
The genetic architecture of the human hypothalamus and its involvement in neuropsychiatric behaviours and disorders
Nature Human Behaviour (2024)
-
Inference of chronic obstructive pulmonary disease with deep learning on raw spirograms identifies new genetic loci and improves risk models
Nature Genetics (2023)
-
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure
Nature Communications (2022)